artificial intelligence

Microsoft Chief Medical Officer and VP of Healthcare Dr. David Rhew discusses how automation can help manage high patient call volumes, unwieldy medical device data and daily employee health screening.

The solution can be used to flag potential risks of COVID-19. 

Group 42 and Oxford Nanopore Technologies have released details of a promising end-to-end solution that can mass screen for SARS-CoV-2.

The partnership aims to reduce pressure on the health system by automating the triage process. 

insitro unveiled a $143 million Series B round on the same day that fellow machine learning company Exscientia highlighted its own $60 million Series C raise.

Medicomp CEO Dave Lareau discusses how his company made early coronavirus-specific changes to its database and AI engine as the pandemic took hold in February and has continued to innovate since then.

Dr. Nathalie Bloch, head of big data and AI at the ARC Innovation Center at Sheba Medical Center, Israel, discusses the use of AI in dealing with COVID-19 patients in this episode of The Alessi Agenda.

AI is steadily proving itself to the clinical community, but there are some aspects of care in which an algorithm will never be granted full control, said Cardiologs CEO Yann Fleureau.

In this HIMSS TV Deep Dive, we show how health systems are leveraging advanced technologies such as AI, analytics and telehealth to manage patient populations while still staying focused on the basic building blocks of health and wellness.

Epstein Becker & Green's Bradley Merrill Thompson describes the agency's current trajectory for regulation of patient-facing and provider-facing telehealth products that incorporate AI.